Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guus Fons

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 29, 2019
Analysis of isolated loco-regional recurrence rate in intermediate risk early cervical cancer after a type C2 radical hysterectomy without adjuvant radiotherapyJacobus van der Velden, Constantijne H Mom, Luc van Lonkhuijzen, et al.
Gynecologic Oncology|October 17, 2020
Radiotherapy is not indicated in patients with vulvar squamous cell carcinoma and only one occult intracapsular groin node metastasisJacobus van der Velden, Noortje Pleunis, Ellen Barlow, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 26, 2024
DNA Methylation and p53 Immunohistochemistry as Prognostic Biomarkers for Vulvar Lichen SclerosusFéline O Voss, Johannes Berkhof, Sylvia Duin, et al.
Gynecologic Oncology|December 13, 2024
Prevalence and impact of vulvar lesions diagnosed prior to vulvar squamous cell carcinoma: A population-based cohort studyFéline O Voss, Guus Fons, Annette H Bruggink, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 14, 2009
Prognostic value of bilateral positive nodes in squamous cell cancer of the vulvaGuus Fons, Simon E Hyde, Marrije R Buist, et al.
Gynecologic Oncology|April 21, 2012
Long-term sexual function in survivors of vulvar cancer: a cross-sectional studyMenke H Hazewinkel, Ellen T M Laan, Mirjam A G Sprangers, et al.
BMC Cancer|April 24, 2022
Sentinel lymph node procedure in patients with recurrent vulvar squamous cell carcinoma: a proposed protocol for a multicentre observational studyHelena C van Doorn, Maaike H M Oonk, Guus Fons, et al.
Cancers|November 27, 2021
Biomarker Expression in Multifocal Vulvar High-Grade Squamous Intraepithelial LesionsNikki B Thuijs, Willemijn A M Schonck, Linde L J Klaver, et al.
Cancers|January 11, 2025
Impact of the Number of Positive Pelvic Lymph Nodes on Risk of Para-Aortic Recurrence in Patients with Clinically Early Cervical Cancer Treated by a Radical Hysterectomy and Pelvic LymphadenectomyFelix J M Schoonhoven, Johanna W M Aarts, Guus Fons, et al.
Journal for Immunotherapy of Cancer|October 26, 2021
Immune landscape in vulvar cancer-draining lymph nodes indicates distinct immune escape mechanisms in support of metastatic spread and growthAnne Marijne Heeren, Jossie Rotman, Sanne Samuels, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 29, 2019
Analysis of isolated loco-regional recurrence rate in intermediate risk early cervical cancer after a type C2 radical hysterectomy without adjuvant radiotherapyJacobus van der Velden, Constantijne H Mom, Luc van Lonkhuijzen, et al.
Gynecologic Oncology|October 17, 2020
Radiotherapy is not indicated in patients with vulvar squamous cell carcinoma and only one occult intracapsular groin node metastasisJacobus van der Velden, Noortje Pleunis, Ellen Barlow, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 26, 2024
DNA Methylation and p53 Immunohistochemistry as Prognostic Biomarkers for Vulvar Lichen SclerosusFéline O Voss, Johannes Berkhof, Sylvia Duin, et al.
Gynecologic Oncology|December 13, 2024
Prevalence and impact of vulvar lesions diagnosed prior to vulvar squamous cell carcinoma: A population-based cohort studyFéline O Voss, Guus Fons, Annette H Bruggink, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 14, 2009
Prognostic value of bilateral positive nodes in squamous cell cancer of the vulvaGuus Fons, Simon E Hyde, Marrije R Buist, et al.
Gynecologic Oncology|April 21, 2012
Long-term sexual function in survivors of vulvar cancer: a cross-sectional studyMenke H Hazewinkel, Ellen T M Laan, Mirjam A G Sprangers, et al.
BMC Cancer|April 24, 2022
Sentinel lymph node procedure in patients with recurrent vulvar squamous cell carcinoma: a proposed protocol for a multicentre observational studyHelena C van Doorn, Maaike H M Oonk, Guus Fons, et al.
Cancers|November 27, 2021
Biomarker Expression in Multifocal Vulvar High-Grade Squamous Intraepithelial LesionsNikki B Thuijs, Willemijn A M Schonck, Linde L J Klaver, et al.
Cancers|January 11, 2025
Impact of the Number of Positive Pelvic Lymph Nodes on Risk of Para-Aortic Recurrence in Patients with Clinically Early Cervical Cancer Treated by a Radical Hysterectomy and Pelvic LymphadenectomyFelix J M Schoonhoven, Johanna W M Aarts, Guus Fons, et al.
Journal for Immunotherapy of Cancer|October 26, 2021
Immune landscape in vulvar cancer-draining lymph nodes indicates distinct immune escape mechanisms in support of metastatic spread and growthAnne Marijne Heeren, Jossie Rotman, Sanne Samuels, et al.
Pageof 3